Biodistribution of hypericin in orthotopic transitional cell carcinoma bladder tumors: Implication for whole bladder wall photodynamic therapy

International Journal of Cancer

Volumn 97, Issue 2, 2002, Pages 253-260

  Kamuhabwa, Appolinary A R ^a   Cosserat Gerardin, Isabelle ^b   Didelon, Jacques ^c   Notter, Dominique ^b   Guillemin, François ^c   Roskams, Tania ^d   D'Hallewin, Marie Ange ^d   Baert, Luc ^d   De Witte, Peter A M ^a  

^a Faculteit Farmaceutische Wetenschappen   (Belgium)

^b UNIVERSITÉ DE LORRAINE   (France)

^c CENTRE ALEXIS VAUTRIN   (France)

^d UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

AY 27; Biodistribution; Hypericin; Orthotopic

Indexed keywords

HYPERICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER CARCINOMA; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG INSTILLATION; DRUG PENETRATION; FEMALE; FLUORESCENCE MICROSCOPY; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RAT; SUBMUCOSA; SUPERFICIAL CANCER; TRANSITIONAL CELL CARCINOMA; TUMOR CELL DESTRUCTION; UROTHELIUM;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, TRANSITIONAL CELL; FEMALE; MODELS, ANIMAL; PERYLENE; PHOTOCHEMOTHERAPY; RADIATION-SENSITIZING AGENTS; RATS; TISSUE DISTRIBUTION; TREATMENT OUTCOME; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0037049987     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.1594     Document Type: Article

References (42)

1. Epidemiological characteristics of squamous cell carcinoma and adenocarcinoma of the bladder
2. Bladder carcinoma and a TMN system for classification
3. Longitudinal study of patients with bladder cancer: Factors associated with disease recurrence and progression
4. Superficial bladder cancer: Progression and recurrence
5. Mapping of the urinary bladder: Its impact on the concepts of bladder cancer
6. Carcinoma in situ of the urothelium
7. Carcinoma in situ of the bladder
8. Photodynamic therapy: Principles and urological applications
9. Clinical fluorescence diagnosis of human bladder carcinoma following low photofrin injection
10. Complications of whole bladder dihematoporphyrin ether photodynamic therapy
11. Whole bladder whole photodynamic therapy with in situ light dosimetry for carcinoma in situ of the bladder
12. Detection of early bladder cancer by 5 aminolevulinic acid induced porphyrin fluorescence
13. Fluorecence detection of flat carcinoma ins situ of the bladder after intravesical instillation with ALA
14. Fluorescence detection of bladder tumors with 5-aminolevulinic acid
15. Frequent genetic alterations in simple urothelial hyperplasia of the bladder in patients with papillary urothelial carcinoma
16. Photodetection of early human bladder cancer based on the fluorescence of 5-aminolevulinic acid hexyelester-induced protoporphyrin IX: A pilot study
17. Photocytotoxicity effect of pseudohypericin versus hypericin
18. Photodynamic activity of hypericin in human urinary bladder carcinoma cells
19. In vivo photodynamic activity of hypericin in transitional cell carcinoma tumors
20. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: Aromatic polycyclic diones hypericin and pseudohypericin
21. Genotoxizität eines standardisierten hypericum-extraktes
22. St. John's wort for depression - An overview and meta-analysis of randomized clinical trials
23. Propriétés photophysiques de l'hypericine en solution et en dispersion micellaire
24. Photosensitization with anticancer agents, 17. EPR studies of photodynamic action of hypericin: Formation of semiquinone radical and activated oxygen species on illumination
25. Investigation of the absorption of hypericin into the skin of hairless mice
26. Fluorescence detection of flat bladder carcinoma in situ after intravesical instillation of hypericin
27. Biodistribution of photofrin II and 5-aminolevulinic acid-induced protoporphyrin IX in normal rat bladder and bladder tumor models: Implications for photodynamic therapy
28. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumor model
29. Skin photosensitization with topical hypericin in hairless mice
30. Autofluorescence spectroscopy of normal and malignant tissues: Both in vivo and ex vivo measurements in the upper aero-digestive tract and lung tissues
31. Determination of the maximal carcinoma/normal skin ratio after HpD or m-THPC administration in hairless mice (SKH-1) by fluorescence spectroscopy
32. Pharmacokinetics and pharmacodynamics of tetra(m-hydroxyphenyl)chlorin in the hamster cheek pouch tumor model: Comparison with clinical measurements
33. In vitro transport and uptake of protohypericin and hypericin in the Caco-2 model
34. Epithelial tumors of the lower urinary tract in humans and rodents
35. Biodistribution and photodynamic effect of protoporphyrin IX in rat urinary bladders after intravesical instillation of 5-aminolevulinic acid
36. Whole bladder photodynamic therapy for transition cell carcinoma of the bladder
37. The morphological and functional changes in rat bladder following photodynamic therapy with phthalocyanine photosensitization
38. Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: Light diffusion and histological changes
39. Biodistribution and phototoxicity of 5-aminolevulininc acid-induced PpIX in an orthotopic rat bladder tumor model
40. Integral photodynamic treatment of refractory superficial bladder cancer
41. Pharmacokinetics of 5-aminolevulinic acid-induced protoporphyrin IX in skin and blood
42. Intravesical administration of 5-aminolevulenic acid (5-ALA): Safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IX